A non-inferiority randomized control trial comparing cognitive-behavior therapy delivered in videoconference or in face-to-face for adults suffering from generalized anxiety disorder.

niversity of Quebec at Outaouais (Université du Québec en Outaouais (UQO)) (Canada)0 个研究点目标入组 46 人开始时间: 2014年11月28日最近更新: 2022年10月24日

试验速览

2021 Results article in https://pubmed.ncbi.nlm.nih.gov/33720024/ results (added 16/03/2021) 2022 Results article in https://doi.org/10.3390/jcm11195924 (added 13/10/2022)

•1. Ambulatory man and woman
•2. At least 18 years old and at most 75 years old
•3. French speaking
•4. Receiving a principal diagnosis of GAD based on DSM-5 diagnostic criteria. Assessed with asemi-structured diagnostic interview (ADIS)
•5. If currently taking medication for GAD, pharmacotherapy must me stabilized (same type and dosage) for at least six months and the GAD remained stable and uncured (i.e. still meeting the diagnostic criteria). Note that there is no perfect solution to the problem of medication since most severe cases already receive Selective Serotonin Reuptake Inhibitor (SSRI) from their doctors when they seek psychological treatments (thus, recruiting non-medicated participants would threaten the feasibility of the study and could lead to the selection of less severe cases) and stopping medication would induce other methodological problems (e.g., withdrawal symptoms, artificial peak of severity at pre-treatment, ethical issues)

•1. Having a principal diagnosis other than GAD
•2. Currently suffering from a severe organic disease, dementia, mental retardation, schizophrenia, amnesia, substance abuse, borderline personality disorder, psychosis or bipolar disorder
•3. GAD being secondary to a medical condition
•4. Active suicidal ideations
•5. Starting a new medication or changing actual medication

发起方

niversity of Quebec at Outaouais (Université du Québec en Outaouais (UQO)) (Canada)